Nalu Medical, Inc. (“Nalu”), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use of Nalu PNS therapy in chronic pain patients ...
Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. CFTX-1554 is under development for the treatment of peripheral ...
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, announced today that it has received clearance ...